Search This Blog

Monday, November 25, 2019

Arrowhead Pharmaceuticals reports FY results

Arrowhead Pharmaceuticals (NASDAQ:ARWR): FY GAAP EPS of $0.69.
Revenue of $168.79M (+945.8% Y/Y)
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)